Numerous monoclonal antibodies that target proinflammatory cytokines or their receptors (e.g. infliximab, adalimumab, tocilizumab, belimumab, HuMax-IL-15), and cell-surface or co-stimulatory ...

Monoclonal antibodies (mAbs) are manufactured proteins that behave similarly to antibodies found naturally in the body. Researchers initially developed them for treating certain cancers but have ...

New antibody could be promising cancer treatment Date: November 11, 2024 Source: Uppsala University Summary: Researchers have developed a new form of precision medicine, an antibody, with the ...